No profile data available.
Imunon, Inc. (IMNN) is a healthcare company in the additional cancer treatment drugs industry, based in Lawrenceville, United States, with about 20 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$14.50 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $6.06 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States.
Imunon reported $0 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
$6.06 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include CNS Pharmaceuticals, Inc. (CNSP), Aprea Therapeutics, Inc. (APRE), Traws Pharma, Inc. (TRAW), Liminatus Pharma, Inc. (LIMN).